Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance to Cell Death and Its Modulation in Cancer Stem Cells
Ahmad R. Safa
Critical Reviews™ in Oncogenesis (2016) Vol. 21, Iss. 3-4, pp. 203-219
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

The multi-factorial nature of clinical multidrug resistance in cancer
Yehuda G. Assaraf, Anamaria Brozović, Ana Cristina Gonçalves, et al.
Drug Resistance Updates (2019) Vol. 46, pp. 100645-100645
Closed Access | Times Cited: 438
Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Rajendra Karki, Bhesh Raj Sharma, Ein Lee, et al.
JCI Insight (2020) Vol. 5, Iss. 12
Open Access | Times Cited: 204
The α6β4 integrin promotes resistance to ferroptosis
Caitlin W. Brown, John J. Amante, Hira Lal Goel, et al.
The Journal of Cell Biology (2017) Vol. 216, Iss. 12, pp. 4287-4297
Open Access | Times Cited: 163
Cancer cells stemness: A doorstep to targeted therapy
Sahdeo Prasad, Sharavan Ramachandran, Nehal Gupta, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2019) Vol. 1866, Iss. 4, pp. 165424-165424
Open Access | Times Cited: 129
Epithelial‐mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation
Hanmin Wang, Juli Unternaehrer
Developmental Dynamics (2018) Vol. 248, Iss. 1, pp. 10-20
Open Access | Times Cited: 109
CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
Zhe Wang, Kun Zhao, Thilo Hackert, et al.
Frontiers in Cell and Developmental Biology (2018) Vol. 6
Open Access | Times Cited: 106
NF-κB Signalling in Glioblastoma
Vincent Soubannier, Stefano Stifani
Biomedicines (2017) Vol. 5, Iss. 2, pp. 29-29
Open Access | Times Cited: 97
Dietary Phytochemicals Targeting Cancer Stem Cells
Alena Líšková, Peter Kubatka, Marek Samec, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 899-899
Open Access | Times Cited: 84
Role of Mitochondria in Cancer Stem Cell Resistance
José Manuel García-Heredia, Amancio Carnero
Cells (2020) Vol. 9, Iss. 7, pp. 1693-1693
Open Access | Times Cited: 79
Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance
Saeedeh Keyvani‐Ghamsari, Khatereh Khorsandi, Azhar Rasul, et al.
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting
Shweta Bisht, Manisha Nigam, Shyam S. Kunjwal, et al.
Stem Cells International (2022) Vol. 2022, pp. 1-28
Open Access | Times Cited: 52
Synergistic Anti-Cancer Activities of Curcumin Derivative CU17 Combined with Gemcitabine Against A549 Non-Small-Cell Lung Cancer Cells
Narissara Namwan, Gulsiri Senawong, Chanokbhorn Phaosiri, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 158-158
Open Access | Times Cited: 1
Long non‐coding RNA FEZF1‐AS1 promotes breast cancer stemness and tumorigenesis via targeting miR‐30a/Nanog axis
Zhi Zhang, Liwei Sun, Yixuan Zhang, et al.
Journal of Cellular Physiology (2018) Vol. 233, Iss. 11, pp. 8630-8638
Closed Access | Times Cited: 68
Piperine: role in prevention and progression of cancer
Mariia Zadorozhna, Tiziana Tataranni, Domenica Mangieri
Molecular Biology Reports (2019) Vol. 46, Iss. 5, pp. 5617-5629
Closed Access | Times Cited: 66
Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors
Jens C. Hahne, Nicola Valeri
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 65
Pharmacological targeting of mitochondria in cancer stem cells: An ancient organelle at the crossroad of novel anti-cancer therapies
J. Škoda, Karolina Borankova, Patric J. Jansson, et al.
Pharmacological Research (2018) Vol. 139, pp. 298-313
Closed Access | Times Cited: 63
Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming
Zhe Wang, Hanxue Sun, Jan Provazník, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 57
A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer
Tianyu Cao, Yuanyuan Lu, Qi Wang, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 37
Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
Daisy S Precilla, Indrani Biswas, Shreyas S. Kuduvalli, et al.
Cellular Signalling (2022) Vol. 95, pp. 110350-110350
Closed Access | Times Cited: 36
Drug and apoptosis resistance in cancer stem cells (CSCs): A puzzle with many pieces
Ahmad R. Safa
Cancer Drug Resistance (2022) Vol. 5, Iss. 4, pp. 850-72
Open Access | Times Cited: 34
Cancer Stem Cells and the Tumor Microenvironment: Targeting the Critical Crosstalk through Nanocarrier Systems
Aadya Nayak, Neerada Meenakshi Warrier, Praveen Kumar
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 7, pp. 2209-2233
Open Access | Times Cited: 30
Role of Nanotechnology in Overcoming the Multidrug Resistance in Cancer Therapy: A Review
Suhail Ahmad Mir, Laraibah Hamid, Ghulam Nabi Bader, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6608-6608
Open Access | Times Cited: 29
Exploring beyond Common Cell Death Pathways in Oral Cancer: A Systematic Review
Leonardo de Oliveira Siquara da Rocha, Éverton Freitas de Morais, Lilianny Querino Rocha de Oliveira, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 103-103
Open Access | Times Cited: 8
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 6
Negative regulators of cell death pathways in cancer: perspective on biomarkers and targeted therapies
Ali Razaghi, Kirsten Heimann, Patrick M. Schaeffer, et al.
APOPTOSIS (2018) Vol. 23, Iss. 2, pp. 93-112
Closed Access | Times Cited: 51
Page 1 - Next Page

Scroll to top